• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

‘No More Paying For The Rich World’s Medicine’ – White House

13/02/2019 by Intellectual Property Watch 4 Comments

The Trump administration yesterday made some firm statements about reducing health care and drug prices for American consumers and making costs more transparent. The statements again appear to focus on other countries paying more for US-made drugs but also promote generic drugs.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, English, Health & IP, North America, Patents/Designs/Trade Secrets, Regional Policy

Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive

13/02/2019 by William New, Intellectual Property Watch Leave a Comment

The government of Malaysia continues to face pressure from the United States pharmaceutical industry and potentially the US government to undo an action taken to make a key hepatitis C medicine more affordable in the country. Now Médecins Sans Frontières (MSF, Doctors Without Borders) has weighed in to defend the government’s right to use a patent flexibility in global trade law that allows them to take such actions on behalf of their citizens.

Filed Under: IP Policies, Themes, Venues, Asia/Pacific, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

TRIPS Council To Look At IP And The Public Interest, Business Interest

11/02/2019 by William New, Intellectual Property Watch Leave a Comment

The World Trade Organization is the prime gathering point for the world’s governments to discuss and negotiate on policies of the day. A decades-long swinging pendulum within the WTO’s committee on trade and intellectual property is IP’s contribution to innovation and economy and its contribution to the public interest. At its meeting this week, the committee will feature discussions on both.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Copyright Policy, Enforcement, English, Environment, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

New High-Tech System Against Falsified Medicines Goes Live In Europe

08/02/2019 by William New, Intellectual Property Watch Leave a Comment

A ground-breaking new high-tech system to catch falsified medicines in the supply chain in Europe went into effect today, allowing prescription medicines to undergo verification for authenticity before reaching patients.

Filed Under: IP Policies, Language, Themes, Venues, Enforcement, English, Europe, Health & IP, New Technologies, Regional Policy, Trademarks/Geographical Indications/Domains

Pre-Grant Opposition Filed Against Janssen’s Bedaquiline Fumarate Application In India

08/02/2019 by Intellectual Property Watch 2 Comments

Tuberculosis and its variant – Drug Resistant Tuberculosis (DR-TB) – are global public health emergencies. Current treatment regimens are expensive, tedious and prolonged: the overall treatment duration is 20 months or more, requiring daily administration of drugs that are more toxic and less effective than those used to treat drug-susceptible TB. Most of the drugs for treating TB are old and are known to have severe side-effects, writes Sandeep K. Rathod.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

IP Still At Heart Of Access To Medicines Discussions At WHO

07/02/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment

Intellectual property is often pointed at as hindering access to medicines by resulting in their long-lasting unaffordability, a view which is strongly opposed by IP proponents. The discussions on access to medicines last week during the World Health Organization Executive Board meeting yielded a record number of interventions by member states and nongovernmental organisations, reflecting the importance of the issue.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, Lobbying, Patents/Designs/Trade Secrets, WHO, WTO/TRIPS

Trump Highlights IP, Trade, Drug Prices In Speech To Congress

06/02/2019 by William New, Intellectual Property Watch 1 Comment

President Donald Trump gave the US Congress a rosy, nationalistic presentation of the condition of the US economy and security last night and amid the range of issues raised, mentioned intellectual property twice in the context of trade, and extensively discussed lowering drug prices.

Filed Under: IP Policies, Themes, Venues, Copyright Policy, Enforcement, English, Finance, Health & IP, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

TRIPS Debated As WHO Board Reaches Agreement On Universal Health Coverage

05/02/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment

World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations in which intellectual property rights played a significant role.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA

04/02/2019 by Catherine Saez, Intellectual Property Watch 3 Comments

The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, New Technologies, Patents/Designs/Trade Secrets, WHO

WHO Governance Questioned As It Adds World Health Assembly Agenda Item On Biodiversity

01/02/2019 by Catherine Saez, Intellectual Property Watch 3 Comments

The World Health Organization today admitted to an unusual procedure to set up a debate on the health implications of a UN treaty on sharing of benefits from genetic resources. The new agenda item proposed by the WHO director general was accepted by the WHO Board today, but with member states questioning the governance of the move.

Filed Under: IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Other International Orgs, Patents/Designs/Trade Secrets, WHO

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 199
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting